Carbimazole

Specifications

22232-54-8CAS Number

244-854-4EC Number

ethyl 3-methyl-2-sulfanylideneimidazole-1-carboxylateIUPAC Name

C7H10N2O2SChemical Formula

186.23 g/molMolecular Weight

Carbimazole; 22232-54-8; Athyromazole; Carbimazol; Carbethoxymethimazole; Carbinazole; Carbimazolum; Ethyl 3-methyl-2-thioimidazoline-1-carboxylate; Carbimazol henning; DTXSID9022736; NSC-758966; CHEBI:617099; 8KQ660G60G; ethyl 3-methyl-2-sulfanylidene-2,3-dihydro-1H-imidazole-1-carboxylate; 1H-Imidazole-1-carboxylic acid, 2,3-dihydro-3-methyl-2-thioxo, ethyl ester; DTXCID902736; Carbimazolo; Neo-mercazole 5; Neo-mercazole 20; RefChem:54713; H03BB01; 244-854-4; Neomercazole; Basolest; Neo-Thyreostat; TYRAZOL; Thyrostat; Carbimazolum [INN-Latin]; Carbimazol [INN-Spanish, French]; Ethyl 3-methyl-2-thioxo-2,3-dihydro-1H-imidazole-1-carboxylate; 1H-Imidazole-1-carboxylic acid, 2,3-dihydro-3-methyl-2-thioxo-, ethyl ester; MFCD00027421; Carbimazole (INN); 3-Methyl-2-thioxo-4-imidazoline-1-carboxylic acid ethyl ester; Neo-Mercazole; ethyl 3-methyl-2-sulfanylideneimidazole-1-carboxylate; Atirozidina; Carbotiroid; Mertiran; CG1; 4-Imidazoline-1-carboxylic acid, 3-methyl-2-thioxo-, ethyl ester; Carbimazol spofa; Neo-Tireol; CHEMBL508102; Ethyl 3-methyl-2-thionoimidazoline-1-carboxylate; NCGC00016760-01; CAS-22232-54-8; CARBIMAZOLE [INN]; 2,3-Dihydro-3-methyl-2-thioxo-1H-imidazole-1-carboxylic acid ethyl ester; 1-Ethoxycarbonyl-3-methyl-2-thioxo-4-imidazoline; Carbimazole [INN:BAN:DCF]; 1-Ethoxycarbonyl-3-methyl-2-thioimidazol; ethyl 3-methyl-2-thioxo-4-imidazolinecarboxylate; SR-01000872660; EINECS 244-854-4; BRN 0144339; UNII-8KQ660G60G; Carbimazole CRS; Prestwick_788; Fenobucarb Bassa BPMC; Carbimazole (Standard); CARBIMAZOLE [MI]; Prestwick0_000439; Prestwick1_000439; Prestwick2_000439; Prestwick3_000439; Spectrum2_001251; Spectrum3_001968; Epitope ID:116890; 1-ethoxycarbonyl-3-methyl-2-thio-4-imidazoline; ethyl 3-methyl-2-thioxo-imidazole-1-carboxylate; CARBIMAZOLE [MART.]; SCHEMBL44211; BSPBio_000458; BSPBio_003568; CARBIMAZOLE [WHO-DD]; 4-24-00-00064 (Beilstein Handbook Reference); MLS004734638; SPECTRUM1505323; SPBio_001182; SPBio_002397; BPBio1_000504; orb1225626; orb1310136; HY-B0558R; KBio3_002918; CARBIMAZOLE [EP MONOGRAPH]; HMS1569G20; HMS1922D12; HMS2096G20; HMS3652G04; HMS3713G20; HMS5082P21; Pharmakon1600-01505323; Carbimazole - Bio-X trade mark; HY-B0558; MSK11357; Tox21_110596; Tox21_302320; BDBM50275889; CCG-39106; EBC-26162; NSC758966; s4048; SBB058031; AKOS001647527; Tox21_110596_1; AC-8348; DB00389; FE19698; NSC 758966; NCGC00016760-02; NCGC00016760-03; NCGC00016760-04; NCGC00016760-05; NCGC00016760-08; NCGC00095167-01; NCGC00095167-02; NCGC00177988-01; NCGC00177988-02; NCGC00255133-01; AS-13267; BE164282; SMR001233183; SY049868; SBI-0207026.P001; NS00005246; ST50825250; SW196926-3; C07615; C74138; D07616; EN300-7816879; 3-METHYL-2-THIOI-MIDAZOLINE-1-CARBOXYLATE; F053981; Q414013; SR-01000872660-1; SR-01000872660-2; BRD-K87156652-001-05-1; BRD-K87156652-001-06-9; BRD-K87156652-001-11-9; BRD-K87156652-001-12-7; BRD-K87156652-001-13-5; 3-Methyl-2-thioxo-4-imidazoline-1-carboxylic acid ethyl est er; Ethyl 3-methyl-2-thioxo-2,3-dihydro-1H-imidazole-1-carboxylate #Synonyms